Incyte Corporation (INCY)
Working capital turnover
Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 4,209,569 | 3,949,271 | 3,765,356 | 3,693,101 | 3,609,260 | 3,513,520 | 3,470,962 | 3,395,993 | 3,330,147 | 3,320,472 | 3,114,784 | 2,986,267 | 2,912,923 | 2,720,579 | 2,702,913 | 2,666,702 | 2,456,582 | 2,387,520 | 2,229,409 | 2,158,759 |
Total current assets | US$ in thousands | 3,239,030 | 2,808,710 | 4,849,090 | 4,645,400 | 4,402,660 | 4,264,430 | 3,971,630 | 4,092,850 | 3,821,110 | 3,625,840 | 3,288,090 | 3,118,670 | 2,923,800 | 2,620,060 | 2,449,970 | 2,359,890 | 2,159,420 | 2,077,620 | 1,716,170 | 2,481,490 |
Total current liabilities | US$ in thousands | 1,641,850 | 1,501,650 | 1,396,450 | 1,240,380 | 1,124,680 | 1,118,770 | 1,006,110 | 1,157,080 | 1,006,600 | 926,674 | 886,163 | 854,308 | 742,712 | 660,324 | 623,881 | 631,195 | 606,202 | 556,513 | 503,412 | 513,340 |
Working capital turnover | 2.64 | 3.02 | 1.09 | 1.08 | 1.10 | 1.12 | 1.17 | 1.16 | 1.18 | 1.23 | 1.30 | 1.32 | 1.34 | 1.39 | 1.48 | 1.54 | 1.58 | 1.57 | 1.84 | 1.10 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $4,209,569K ÷ ($3,239,030K – $1,641,850K)
= 2.64
Working capital turnover is a financial ratio that measures how efficiently a company utilizes its working capital to generate sales revenue. A higher working capital turnover ratio indicates better efficiency in managing working capital.
Analyzing Incyte Corporation's working capital turnover over the last few years, we observe a fluctuating trend:
- The working capital turnover ratio was 1.10 as of December 31, 2019, indicating that for every dollar of working capital, the company generated $1.10 in sales revenue.
- The ratio improved to 1.84 by March 31, 2020, reflecting a more efficient utilization of working capital.
- Subsequently, the ratio fluctuated between 1.57 and 1.48 over the next year, showing some variability in working capital efficiency.
- By September 30, 2021, the ratio declined to 1.34, indicating a slight decrease in efficiency.
- The ratio continued to decrease, reaching 1.08 by December 31, 2023.
The most significant change occurred in the later part of 2024, with a sudden spike in working capital turnover to 3.02 on September 30, 2024, and 2.64 by December 31, 2024, which could be attributed to various factors such as changes in company operations, sales growth, or working capital management strategies.
Overall, Incyte Corporation's working capital turnover has seen fluctuations, with periods of both improvement and decline in efficiency. It is essential for the company to closely monitor and manage working capital effectively to sustain and enhance operational efficiency and financial performance.
Peer comparison
Dec 31, 2024